PAID-20 Diabetes Distress Assessment
Clinical Purpose
Diabetes distress — the emotional burden specific to living with and managing diabetes — is distinct from generalised depression and anxiety, yet is independently associated with poorer glycaemic control, reduced treatment adherence, and lower quality of life. It is prevalent across both type 1 and type 2 diabetes and is frequently under-recognised in routine care.
This pathway delivers the Problem Areas In Diabetes (PAID-20) questionnaire: a 20-item validated self-report instrument that quantifies the degree to which specific aspects of diabetes management are experienced as emotionally burdensome. It was developed and first validated by Polonsky et al. (1995) and has been widely adopted in diabetes services internationally as both a clinical conversation starter and a longitudinal monitoring tool.
Target Population
Adults living with diabetes (type 1 or type 2) who are under the care of a diabetes service. The questionnaire is appropriate for use at initial assessment, routine review, or any point where a clinician suspects elevated emotional burden related to diabetes management.
Scoring
Respondents rate each of the 20 items from 0 (not a problem) to 4 (serious problem). The raw item scores are summed and multiplied by 1.25 to yield a total score on a 0–100 scale.
| Item score | Interpretation |
|---|---|
| 3 or 4 on any single item | Moderate-to-severe distress in that specific domain; merits direct discussion at the next appointment |
| Total ≥ 40 | Severe overall diabetes distress; warrants prompt clinical review and consideration of psychological support |
Source: Polonsky WH, Anderson BJ, Lohrer PA, et al. Assessment of diabetes-related distress. Diabetes Care. 1995;18(6):754–60.
Clinical Use
The PAID-20 is most usefully interpreted at the item level as well as by total score. Reviewing the highest-scoring items with the patient can help prioritise which aspects of diabetes management to address in the consultation. Serial administration (e.g. at each annual or six-monthly review) allows tracking of distress over time and assessment of response to interventions.
The scale does not replace a clinical assessment of depression or anxiety; patients with high scores should be assessed for comorbid mood disorder using validated instruments where clinically indicated (e.g. PHQ-9, GAD-7).
Expected Outcomes
On completion of the questionnaire, the clinical team receives the patient's item-level responses and total score. Items rated 3 or 4, and total scores of 40 or above, should be flagged for clinical review. The pathway does not calculate a composite score automatically; scoring is applied by the clinical team or an upstream integration using the PAID-20 algorithm (sum × 1.25).
References
- Polonsky WH, Anderson BJ, Lohrer PA, Welch G, Jacobson AM, Aponte JE, Schwartz CE. Assessment of diabetes-related distress. Diabetes Care. 1995;18(6):754–60.
- Snoek FJ, Pouwer F, Welch GW, Polonsky WH. Diabetes-related emotional distress in Dutch and U.S. diabetic patients. Diabetes Care. 2000;23(9):1305–9.
- Welch GW, Jacobson AM, Polonsky WH. The Problem Areas In Diabetes Scale: an evaluation of its clinical utility. Diabetes Care. 1997;20(5):760–6.
Pathway
Form preview
Interactive preview of the questionnaire. Not for clinical use. Responses are not stored.